Regulation of EGF signaling transduction in breast cancer-initiating cells and their niches
Project/Area Number |
24700968
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Tumor biology
|
Research Institution | The University of Tokyo |
Principal Investigator |
MIZUTANI ANNA 東京大学, 医学(系)研究科(研究院), 特任研究員 (30615159)
|
Project Period (FY) |
2012-04-01 – 2014-03-31
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2013: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2012: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Keywords | がん幹細胞 / 乳がん / 癌幹細胞 |
Research Abstract |
Recently cancer-initiating cells have been considered to be important targets in chemotherapy. Our data using breast cancer cell lines shows transforming growth factor (TGF)-beta signaling is involved in cancer-initiating like cell maintenance in addition to epidermal growth factor (EGF) and fibroblast growth factor (FGF) signaling. We previously showed that epithelial splicing regulatory protein (ESRP) was transcriptionally down-regulated by TGF-beta. ESRPs are involved in mRNA splicing widely. We investigated the regulatory mechanisms of ESRPs. Here we obtained the data which could be a clue to understand the regulatory mechanism of ESRPs.
|
Report
(3 results)
Research Products
(5 results)